Canal Capital Management’s GSK GSK Stock Holding History

Canal Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$356K	Hold	6,800	–	–	0.04%	170
2026 Q1	$375K	Hold	6,800	–	–	0.05%	150
2025 Q4	$333K	Hold	6,800	–	–	0.05%	145
2025 Q3	$293K	Sell	6,800 -1,610	-19%	-$62.9K	0.04%	155
2025 Q2	$323K	Hold	8,410	–	–	0.05%	142
2025 Q1	$326K	Sell	8,410 -228	-3%	-$8.35K	0.05%	134
2024 Q4	$292K	Sell	8,638 -6,067	-41%	-$218K	0.05%	147
2024 Q3	$601K	Buy	14,705 +132	+0.9%	+$5.4K	0.1%	93
2024 Q2	$561K	Hold	14,573	–	–	0.1%	91
2024 Q1	$625K	Sell	14,573 -403	-3%	-$16.6K	0.1%	84
2023 Q4	$555K	Sell	14,976 -533	-3%	-$19.1K	0.1%	96
2023 Q3	$562K	Buy	15,509 +567	+4%	+$20.1K	0.11%	87
2023 Q2	$533K	Hold	14,942	–	–	0.11%	90
2023 Q1	$532K	Sell	14,942 -516	-3%	-$18.1K	0.12%	92
2022 Q4	$543K	Buy	15,458 +1,040	+7%	+$34.6K	0.13%	100
2022 Q3	$424K	Buy	+14,418	New	+$546K	0.12%	96

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Canal Capital Management's GSK Position: Q2 2026 in Review

Canal Capital Management held its GSK (GSK) position steady in Q2 2026 at 6,800 shares worth $356K. The position accounts for 0.04% of the portfolio, ranked #170.

Canal Capital Management first reported a position in GSK in Q3 2022 and has held it in 16 quarters since. The position peaked at $625K in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Canal Capital Management held 6,800 shares of GSK worth $356K as of Q2 2026.
Canal Capital Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.04% of Canal Capital Management's portfolio in Q2 2026, its #170 holding.
Canal Capital Management first reported a position in GSK in Q3 2022 and has held it in 16 quarters since.
Canal Capital Management's GSK position peaked at $625K in Q1 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Canal Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.